Ms. Jiang Huixia, founder of Bio Innovators Fund, has focused on life and health industry community, education and training, investment incubation, industry media, cross-border cooperation and other operations for more than ten years. At the same time, she takes the role of angel investor and entrepreneurial mentor, having led investments for and successfully incubated more than 30 early projects in the fields of life and health such as Acrobiosystems and Yucebio.
In a recent session of Fudan MBA Jujing Forum, Jiang pointed out that in recent years, with changes in the domestic and external environment, driven by the "Healthy China" strategy and innovations, by people's higher demand for health, and especially by the outbreak of the epidemic, the development of the medical and health industry has entered the "fast lane", showing rapid growth and strong demand. Successful cases of representative companies have encouraged capital into the industry, shifting its development paradigm to "big industry, big demand".
Later, Ms. Jiang took the R&D of innovative drugs as an example to demonstrate that our medical and health industry and innovative drug R&D enterprises are still far from the world's advanced level, and there is still great potential in promoting industrial autonomy and internationalization. In the field of medical equipment, product homogeneity is still serious, while independent innovation capabilities are not yet strong enough. These have brought both challenges and opportunities to the development of the industry.
Jiang then shared the success factors and entrepreneurial risks of excellent medical enterprises, as well as her own logic of project incubation and transformation.
